MedTrace Logo

CTTI Risk Factors for HABP/VABP Study

NCT02689531 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 7530

Last updated 2023-06-15

No results posted yet for this study

Summary

The purpose of this study is to better define the intensive care unit population at highest risk for developing Hospital-Acquired and Ventilator-Associated Bacterial Pneumonia (HABP/VABP).

Conditions

  • Pneumonia, Ventilator-Associated
  • Pneumonia, Bacterial
  • Pneumonia, Hospital-Acquired

Sponsors & Collaborators

  • Clinical Trials Transformation Initiative

    collaborator OTHER

  • Food and Drug Administration (FDA)

    collaborator FED

  • Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

    collaborator NIH

  • Duke University

    lead OTHER

Principal Investigators

  • Vance G Fowler, MD, MHS · Duke University

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-02-29
Primary Completion
2018-02-28
Completion
2018-02-28

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02689531 on ClinicalTrials.gov